PDUFA dates September 2022: FDA calendar and catalysts.
0 PDUFA dates fell in September 2022. The FDA calendar also recorded 32 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in September 2022
No PDUFA dates are disclosed for this period as of November 16, 2026.
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
September 2022: other FDA decisions and filings
September 2022: dated readouts
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Sep 2022Month disclosed | ABP-450 | AEON | Topline readout | — | Met primary endpoint | SEC Form 10-Q |
| Sep 2022Month disclosed | Ampligen® (rintatolimod) | AIM | Topline readout | — | Negative | SEC Form 10-Q |
| Sep 2022Month disclosed | — | ARQT | Topline readout | — | Positive | SEC Form 10-K |
| Sep 2022Month disclosed | ZORYVE (roflumilast) | ARQT | Topline readout | — | Positive | SEC Form 10-Q |
| Sep 2022Month disclosed | — | ARQT | Topline readout | — | Positive | SEC Form 10-K |
| Sep 2022Month disclosed | verdiperstat | BHVN | Topline readout | participants with ALS | Negative | SEC Form 10-K |
| September 27, 2022 | — | NCEL | Topline readout | — | Positive | SEC Form 10-K |
September 2022: trial starts and primary completions
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Sep 2022Month disclosed | AUVELITY (dextromethorphan-bupropion) | AXSM | Trial start | AD agitation | Completed | SEC Form 10-K |
| Sep 2022Month disclosed | MRT-2359 | GLUE | Trial start | — | Completed | SEC Form 10-K |
| Sep 2022Month disclosed | atebimetinib | IMRX | Trial start | with advanced or metastatic solid tumors | Completed | SEC Form 10-Q |
| Sep 2022Month disclosed | efzofitimod (ATYR1923) | ATYR | Trial start | — | Completed | sec_424b |
Questions
What PDUFA dates are in September 2022?
0 PDUFA dates fell in September 2022. The FDA calendar also recorded 32 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.